Target intelligence / Profile preview

RNA, U6 small nuclear 112, pseudogene (RNU6-112P)

Target
RNU6-112P
Molecular classification
Other (noncoding RNA pseudogene)
01

Overview

RNA, U6 small nuclear 112, pseudogene (RNU6-112P) is a member of the large family of U6 small nuclear RNA (snRNA) pseudogenes found throughout vertebrate genomes[1][3]. U6 snRNA itself is a highly conserved, uridine-rich non-coding RNA that is essential for the catalytic activity of the spliceosome, driving intron removal during pre-mRNA splicing[1][2][3]. However, RNU6-112P is designated as a *pseudogene*: it is genetically similar to the functional U6 snRNA gene but does not encode a functional RNA nor participate in spliceosome formation or RNA processing. U6 pseudogenes are scattered throughout the human genome, often created by retrotransposition or template switching events, and may contribute to genomic architecture but do not contribute to cellular function, disease mechanisms, or serve as drug targets[3][4]. There is no evidence that RNU6-112P has a biological function, disease association, or drug interaction. The designation "RNA, U6 small nuclear 112, pseudogene" is correct for this specific locus, but it should not be confused with the active U6 snRNA (RNU6-1), which is a spliceosomal RNA, nor considered a bona fide therapeutic target.

Other names
RNU6-112PU6 small nuclear RNA pseudogene 112U6 snRNA pseudogene
02

Mechanism of action

None

03

Biological functions

None (pseudogene; noncoding and not transcribed to functional product)
04

Disease associations

None established
05

Safety considerations

None known; not pharmacologically or functionally active
06

Interacting drugs

None
07

Biomarkers

None

Beyond the preview

Go deeper on RNA, U6 small nuclear 112, pseudogene (RNU6-112P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U6 small nuclear 112, pseudogene (RNU6-112P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call